Javascript is not enabled.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again.

Skip to content
Content starts here


Leaving Website

You are now leaving and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.

When Can You Get Another Bivalent COVID Booster Shot?

The updated vaccines were introduced last fall. Is a spring shot on the horizon for some?

spinner image COVID-19 Vaccine card with vaccine vial and needle
Getty Images

It’s been about six months since health officials introduced the updated bivalent COVID-19 vaccine to help boost defenses against the disease that has killed more than 1.1 million Americans, most of whom were 50 or older. Now many are wondering: When’s the next shot?

“That’s actually among the most frequently asked questions at the present time,” says William Schaffner, M.D., a professor of preventive medicine and infectious diseases at Vanderbilt University School of Medicine and medical director of the National Foundation for Infectious Diseases.

spinner image Image Alt Attribute

AARP Membership— $12 for your first year when you sign up for Automatic Renewal

Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine.

Join Now

Since the COVID-19 vaccines were first made available, in late 2020, older adults have been encouraged to roll up their sleeves for a jab about every six months — first with the original booster, then the second booster, followed by the omicron-specific shot. But that could change going forward.

The Food and Drug Administration (FDA) has proposed simplifying the vaccine schedule and making the COVID booster a once-a-year shot, much like the flu vaccine. Proponents say this more spaced-out schedule could help to bolster vaccination rates, which lagged with the latest bivalent option. Only about 16 percent of eligible Americans have received one, federal data shows.

Plus, on a population level, protection looks pretty good against severe disease, Schaffner says. According to December 2022 data, adults who received the bivalent booster are significantly less likely to be hospitalized with COVID-19 than their unvaccinated peers. And recent research from the Centers for Disease Control and Prevention (CDC) shows the new booster is effective against the now dominant XBB.1.5 variant.

Still, the strength of the vaccine’s protection against infection and illness does wane some over time, studies show. And that can be concerning for people who are immunocompromised or at high risk for severe COVID for another reason.

What is a bivalent booster?

The updated boosters are called bivalent vaccines, meaning they contain not one but two sets of instructions (mRNA) that teach the body to produce antibodies to fight off a coronavirus infection. One mRNA component is from the original strain of the coronavirus. This is “to provide an immune response that is broadly protective against COVID-19,” the FDA says. The other is from more recently circulating strains of the omicron variant.

Waiting on word of a spring booster

Currently, health officials are not recommending that high-risk individuals get a second dose of the bivalent booster. And because the booster is available under emergency use authorization (EUA), doctors and pharmacists are encouraged to practice within the recommendations. This means if you’ve already received a bivalent booster, you probably won’t be able to get a second one right now.

However, William Moss, M.D., executive director of the International Vaccine Access Center at Johns Hopkins Bloomberg School of Public Health, said in a recent media briefing that it would be “a reasonable consideration” if a recommendation for a second dose of the bivalent booster was made for vulnerable populations whose last booster dose was “some time ago.” 

Recent reports have hinted that the FDA could OK a spring booster for some high-risk individuals. In a statement to AARP, an FDA spokesperson said the agency is closely monitoring the emerging data and will base any decision on the data. “Importantly, individuals who have not yet received an updated [bivalent] booster are encouraged to speak with their health care provider and consider receiving one,” the FDA spokesperson said.

In the U.K., adults 75 and older and immunocompromised individuals have been cleared to go back for a second bivalent booster this spring. Recommendations are similar in Canada.

Other ways to reduce your risks

While we wait for an official decision, health experts say people can take steps to reduce their risk of encountering COVID and getting seriously ill from it.


AARP® Vision Plans from VSP™

Exclusive vision insurance plans designed for members and their families

See more Insurance offers >

“First of all, it’s wonderful that the weather’s getting better, and we can do many things outside again,” says Kawsar Talaat, M.D., associate professor in the Department of International Health at Johns Hopkins Bloomberg School of Public Health. More outdoor air can decrease the risk of transmission, according to the CDC. So, if the option is available, opt for out over in when getting together with others.

Think twice before heading to crowded gatherings where people are “very excitable,” like a sporting event or concert, Schaffner advises. Another tip: If family or friends are coming to visit, ask people to test ahead of time.

“And very importantly, should you develop symptoms, please get tested right away,” Schaffner says. You may be eligible for a prescription antiviral pill or another treatment that can keep your infection from progressing to a more severe state.

Talaat says it’s possible you will receive some “pushback” from your doctor when it comes to prescribing the pill Paxlovid because it interacts with several other medications that you may be taking. “But often you can work around them,” she says, so ask your doctor if there’s a way to do just that. In a recent study, the antiviral treatment reduced the risk of hospitalization or death from an omicron infection in older adults by nearly half. It’s also been shown to reduce the risk of long COVID.

“There’s a lot that we can do to protect ourselves and our families, even without additional boosters,” Talaat says. “And masks still work really well, especially when you’re traveling or are in a crowded situation.”

Discover AARP Members Only Access

Join AARP to Continue

Already a Member?